Global Antibody Drug Conjugates (ADC) Market is Driven by Emerging Markets

The Antibody Drug Conjugates (ADC) Market is expected to grow at a healthy CAGR in the forecast period of 2020 to 2027 due to the rising prevalence of cancer related disorders.

  • On the other hand, the implementation of stringent FDA guidelines for the drug approval of new drug and adverse effect after the treatment are factors expected to obstruct the antibody drug conjugates (ADC) market growth in the above-mentioned forecast period.

Antibody Drug Conjugates (ADC) Market Scenario

According to Data Bridge Market Research, the market for antibody drug conjugates (ADC) market is accelerating due to the growing cases of breast cancer in female, rising prevalence of cancer and surge in the number of research and clinical trials. Additionally, growing geriatric population, commercialization and favorable regulations and policies positively affect the antibody drug conjugates (ADC) market. Furthermore, technological advancement and product approvals extend profitable opportunities to the antibody drug conjugates (ADC) market players.

Now the question is which the other regions are that antibody drug conjugates (ADC) market is targeting? Data Bridge Market Research has estimated the largest growth in Asia-Pacific because of the presence of key manufacturers of the product, increasing healthcare expenditure and skilled professionals and rise in rate of research and development activities. Europe is considered to be the second largest market because of increasing cancer and bone marrow surgeries. Asia-Pacific is expected to witness significant growth due to the rising government awareness programs and number of generic drugs.

For more analysis on the antibody drug conjugates (ADC) market request for a briefing with our analysts

Antibody Drug Conjugates (ADC) Market Scope

The antibody drug conjugates (ADC) market is segmented on the basis of countries into the U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

  • All country-based analysis of antibody drug conjugates (ADC) market is further analyzed based on maximum granularity into further segmentation. The antibody drug conjugates (ADC) market on the basis of target has been segmented into antibody-protein toxin conjugates, antibody-chelated radionuclide conjugates, antibody-small-molecule drug conjugates and antibody-enzyme conjugates. The indication for antibody drug conjugates (ADC) market includes lymphoma, breast cancer, brain tumor, lung cancer, ovarian cancer and others. On the basis of end-users, the antibody drug conjugates (ADC) market is segmented into hospitals, specialty clinics and others. On the basis of distribution channel, the antibody drug conjugates (ADC) market has also been segmented into hospital pharmacy, retail pharmacy and others.
  • Antibody drug conjugates (ADC) refer to the biopharmaceuticals agents designed as targeted therapy of cancer treatment. These drug conjugates are covalently linked to the antibody or antibody fragment which are directed towards the specific cell surface target expressed on the tumor cells. They are known to be combined with monoclonal antibodies that target the cancer cells. They act by specifically targeting to the tumor antigen surface.

To know more about the study

Key Pointers Covered in the Antibody Drug Conjugates (ADC) Market Industry Trends and Forecast to 2027

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market by Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Cost of Care Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the Report

  • Seattle Genetics, Inc.
  • Genentech Inc.
  • Pfizer Inc.
  • Novartis AG
  • F. Hoffmann-LA Roche Ltd.
  • Bristol -Myers Squibb
  • Merck & Co., Inc.
  • Immunomedics Inc.
  • Takeda Pharmaceuticals Industries Ltd.
  • AbbVie Inc.

Above are the key players covered in the report, to know about more and exhaustive list of antibody drug conjugates (ADC) market companies’, contact us

Research Methodology of Antibody Drug Conjugates (ADC) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@